Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer.
Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer.
复制标题
新型尿素化合物作为FGFR1抑制剂的设计,合成和结构活性关系研究,用于治疗转移性三阴性乳腺癌。
DOI:
10.1016/j.ejmech.2020.112866
复制
发表时间:
2021-01-01
影响因子:
6.7
通讯作者:
German NA
中科院分区:
文献类型:
--
作者:
Ashraf-Uz-Zaman M;Shahi S;Akwii R;Sajib MS;Farshbaf MJ;Kallem RR;Putnam W;Wang W;Zhang R;Alvina K;Trippier PC;Mikelis CM;German NA
Triple-negative breast cancer (TNBC) is an aggressive type of cancer characterized by higher metastatic and reoccurrence rates, where approximately one-third of TNBC patients suffer from the metastasis in the brain. At the same time, TNBC shows good responses to chemotherapy, a feature that fuels the search for novel compounds with therapeutic potential in this area. Recently, we have identified novel urea-based compounds with cytotoxicity against selected cell lines and with the ability to cross the blood-brain barrier in vivo. We have synthesized and analyzed a library of more than 40 compounds to elucidate the key features responsible for the observed activity. We have also identified FGFR1 as a molecular target that is affected by the presence of these compounds, confirming our data using in silico model. Overall, we envision that these compounds can be further developed for the potential treatment of metastatic breast cancer.
登录
查看更多内容
影响因子:
50.5
作者:
Gluz, O.;Nitz, U. A.;Mohrmann, S.
通讯作者:
Mohrmann, S.
影响因子:
2.7
作者:
Ashraf-Uz-Zaman, Md;Sajib, Md Sanaullah;German, Nadezhda A.
通讯作者:
German, Nadezhda A.
影响因子:
3.6
作者:
Benati, Luisa;Bencivenni, Giorgio;Zanardi, Giuseppe
通讯作者:
Zanardi, Giuseppe
影响因子:
2.7
作者:
Bera, Rammohan;Kundu, Amit;Karmakar, Sanmoy
通讯作者:
Karmakar, Sanmoy
影响因子:
3.3
作者:
Dale E;Pehrson AL;Jeyarajah T;Li Y;Leiser SC;Smagin G;Olsen CK;Sanchez C
通讯作者:
Sanchez C